Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
19 drugs in development
By Therapeutic Area
top 6
R&D Momentum
80/100
Pipeline Velocity
51/100
Trial Completion Rate
69/100
Pipeline Concentration
13/100
Pipeline Freshness
61/100
Strategic Signals
Activity
Last 14 days
Facilitating Neuroplastic Changes of Acute Stroke Survivors With Severe Hemiplegia
Clinical and Nutrigenetic Assessment of Zinc in Participants With Prediabetes
Pilot Randomized Controlled Trial of E-cigarette Switching Among Older Adults With Opioid Use Disorder
Subscapularis Repair in Reverse Shoulder Arthroplasty: A Multi-Center Randomized Single Blinded Superiority Study
The Influence of Vasopressin on Observational Learning of Placebo Analgesia
The "Upproach" Approach: A Phase 2 Study Of Upfront Intensity Modulated Proton Beam Therapy (Impt) And Concurrent Chemotherapy For Post-Operative Treatment In Loco-Regionally Advanced Endometrial Cancer
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain
The Use of Acupuncture in Potentiating Functional Recovery in Spinal Cord Injury Subjects
Rehabilitation, NMES and High Protein to Reduce Post ICU Syndrome in the Elderly
Ocular Blood Flow Imaging for Glaucoma Assessment
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)